Kamada to speak at the 2013 IATI- Biomed confrence in Israel

IATI BIOMED 2013 follows the success of previous annual conferences where the Israeli Life Sciences industry hosted 6,000 industry players, engineers and scientists with approximately 1,000 participants from over 40 countries and in excess of 3,500 one-on-one meetings.

Kamada’s presentation, on new clinical developments for Alpha-1 Antitrypsin, will take place at June 10, 4:50pm.